CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Human microbiome for early disease detection and diagnosis
4.1.2. Increased focus on human microbiome therapy
4.1.3. Human microbiome as a newly validated target for drug development
4.1.4. The rise in demand for NGS services
4.2. Market Restraints & Challenges
4.2.1. Lack of expertise and detailed research
4.2.2. Government regulations
4.3. Market Opportunities
4.3.1. Increasing collaborations create growth opportunities
4.3.2. Investigational new drug (IND) requirements for Fecal microbiota
CHAPTER 5 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET – BY RESEARCH
TYPE
5.1. Introduction
5.2. Outsourced
5.3. Internal
CHAPTER 6 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET – BY LABORATORY
TYPE
6.1. Introduction
6.2. Wet labs
6.3. Dry labs
CHAPTER 7 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET - BY APPLICATION
7.1. Introduction
7.2. Whole genome sequencing
7.3. RNA sequencing
7.4. Targeted gene sequencing
7.5. Shotgun sequencing
7.6. Other applications
CHAPTER 8 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET - BY TECHNOLOGY
8.1. Introduction
8.2. Sanger sequencing
8.3. Pyrosequencing
8.4. Sequencing by synthesis
8.5. Sequencing by ligation
8.6. Other technologies
GLOBAL 9 MICROBIOME SEQUENCING SERVICES MARKET - BY END USER
9.1. Introduction
9.2. Pharmaceutical and biotechnology companies
9.3. Academia/research institutes
CHAPTER 10 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET - BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. Asia Pacific
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET - COMPANY
PROFILES
11.1. Base clear B.V.
11.2. Clinical-Microbiomics A/S.
11.3. Mérieux Nutri Sciences.
11.4. EPIBIOME.
11.5. Microbiome Insights Inc.
11.6. Microbiome Therapeutics, LLC.
11.7. Second Genome.
11.8. uBiome.
11.9. Ge Healthcare.
11.10. Zymo Research Corp.
11.11. Diversigen, Inc.
11.12. Shanghai Real Bio Technology Co., Ltd.
11.13. Resphera Biosciences, LLC.
11.14. Open Biome.
11.15. Rancho Bio Sciences.
CHAPTER 12 GLOBAL MICROBIOME SEQUENCING SERVICES MARKET – COMPETITIVE
LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13 MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14 APPENDIX
14.1. List of Tables
14.2. List of Figures
